T. Rowe Price Associates »

Akero Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $109M 3.8M 28.69
2024-06-30 $97M 4.1M 23.47
2024-03-31 $103M 4.1M 25.26
2023-12-31 $86M 3.7M 23.35
2023-09-30 $193M 3.8M 50.58
2023-06-30 $154M 3.3M 46.69
2023-03-31 $100M 2.6M 38.26
2022-12-31 $132M 2.4M 54.80
2022-03-31 $6.5M 455k 14.19
2021-12-31 $25M 1.2M 21.15
2021-09-30 $26M 1.2M 22.35
2021-06-30 $29M 1.2M 24.81
2021-03-31 $26M 893k 29.01
2020-12-31 $17M 658k 25.80
2020-09-30 $16M 503k 30.79
2020-06-30 $3.7M 147k 24.92
2020-03-31 $5.1M 240k 21.20
2019-12-31 $5.0M 226k 22.20
2019-09-30 $4.6M 204k 22.75
2019-06-30 $3.9M 202k 19.15